NASDAQ: SBFM
Sunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?

Insider buying vs selling

Have Sunshine Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SBFM insiders and whales buy or sell their stock.

SBFM Shareholders

What type of owners hold Sunshine Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Malek Chamoun739.12%3,700,000$7.88MInsider
Camille Sebaaly34.85%174,465$371.61kInsider
Steve N. Slilaty25.97%130,000$276.90kInsider
David Natan19.98%100,000$213.00kInsider
Citadel Advisors LLC9.24%46,248$98.51kInstitution
Two Sigma Securities LLC4.69%23,482$50.02kInstitution
Xtx Topco Ltd4.29%21,457$45.70kInstitution
Morgan Stanley2.92%14,634$31.17kInstitution
Commonwealth Equity Services LLC2.68%13,437$28.62kInstitution
Sbi Securities Co Ltd0.37%1,834$3.91kInstitution

1 of 2

SBFM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SBFM2.89%97.11%
IMCC0.46%0.00%
PRFX1.89%0.00%
UPC0.00%2.85%
SXTC10.11%0.00%

Sunshine Biopharma Stock Ownership FAQ

Who owns Sunshine Biopharma?

Sunshine Biopharma (NASDAQ: SBFM) is owned by 24.41% institutional shareholders, 819.92% Sunshine Biopharma insiders, and 0.00% retail investors. Malek Chamoun is the largest individual Sunshine Biopharma shareholder, owning 3.70M shares representing 739.12% of the company. Malek Chamoun's Sunshine Biopharma shares are currently valued at $7.88M.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.